1. Home
  2. HCAI vs INTS Comparison

HCAI vs INTS Comparison

Compare HCAI & INTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

HCAI

Huachen AI Parking Management Technology Holding Co. Ltd. Ordinary Shares

N/A

Current Price

$0.34

Market Cap

20.3M

ML Signal

N/A

Logo Intensity Therapeutics Inc.

INTS

Intensity Therapeutics Inc.

N/A

Current Price

$0.42

Market Cap

24.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
HCAI
INTS
Founded
2004
2012
Country
China
United States
Employees
N/A
N/A
Industry
Miscellaneous manufacturing industries
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
20.3M
24.0M
IPO Year
2025
2023

Fundamental Metrics

Financial Performance
Metric
HCAI
INTS
Price
$0.34
$0.42
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$4.33
AVG Volume (30 Days)
70.4K
3.3M
Earning Date
12-19-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.00
N/A
Revenue
$19,176,987.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$93.94
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.30
$0.19
52 Week High
$10.97
$3.17

Technical Indicators

Market Signals
Indicator
HCAI
INTS
Relative Strength Index (RSI) 33.92 47.60
Support Level $0.34 $0.40
Resistance Level $0.44 $0.54
Average True Range (ATR) 0.04 0.06
MACD 0.00 -0.01
Stochastic Oscillator 28.05 27.23

Price Performance

Historical Comparison
HCAI
INTS

About HCAI Huachen AI Parking Management Technology Holding Co. Ltd. Ordinary Shares

Huachen AI Parking Management Technology Holding Co Ltd is a comprehensive smart parking solutions and equipment structural parts provider. The company manufactures and offer various cubic parking garage products by employing various working principles, such as lifting and shifting, convenient lifting, vertical circulation, vertical lifting, plane moving, alley stacking, multi-layer cycle, horizontal cycle, and car lift.

About INTS Intensity Therapeutics Inc.

Intensity Therapeutics Inc is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers. The company leverages its DfuseRxtechnology platform to create new, proprietary drug formulations that, following direct injection, rapidly disperse throughout a tumor and diffuse therapeutic agents into cancer cells. Intensity's product candidates have the potential to induce an adaptive systemic immune response that not only attacks the injected tumor, but also non-injected tumors. Their pipeline is focused on realizing the full potential of INT230-6 in metastatic and local disease settings to help cancer patients with unmet medical need.

Share on Social Networks: